Pharma group Krka's net profit up 42% to EUR 172m in first nine months

Ljubljana, 21 November - The Novo Mesto-based pharmaceutical group, Krka, generated EUR 1.09 billion in sales revenue in the first nine months of the year, which is 12% more than in the same period last year. Net profit increased by 42% to EUR 171.9 million. Sales were up in all regions and most markets.